MPLT MapLight Therapeutics, Inc.

Fundamentals / CIK 0001770069 / USD

MapLight Therapeutics, Inc. reported $477.2M in total assets and a net loss of $252.0M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MPLT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$150.7MFY 2024 Net Income: -$77.58M2024FY 2025 Net Income: -$161.2M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development $138.3M $68.52M
Total Operating Expenses $169.1M $82.95M
Operating Income -$169.1M -$82.95M
EBITDA -$168.5M -$82.25M
Interest Income $5.52M $4.50M
Net Income -$161.2M -$77.58M
Basic EPS -$18.56 -$105.38
Diluted EPS -$18.56 -$105.38
Basic Shares Outstanding 8.7M 736.2K
Diluted Shares Outstanding 8.7M 736.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $44.21M $53.44M $53.68M $64.62M $27.09M $26.85M $19.79M --
Total Operating Expenses $55.34M $63.55M $64.50M $83.38M $31.50M $30.66M $23.54M --
Operating Income -$55.34M -$63.55M -$64.50M -$83.38M -$31.50M -$30.66M -$23.54M --
EBITDA -$55.21M -$63.40M -$64.34M -$83.24M -$31.40M -$30.53M -$23.38M --
Interest Income $3.09M $2.35M $2.47M $2.47M $1.55M $688K $811K --
Net Income -$51.62M -$60.19M -$60.67M -$79.55M -$29.42M -$29.84M -$22.34M -$21.23M
Basic EPS -$0.97 -$1.32 -$1.34 -- -$37.18 -$39.11 -$29.33 --
Diluted EPS -$0.97 -$1.32 -$1.34 -- -$37.18 -$39.11 -$29.33 --
Basic Shares Outstanding 53.1M 45.4M 45.3M -- 791.1K 763.0K 761.6K --
Diluted Shares Outstanding 53.1M 45.4M 45.3M -- 791.1K 763.0K 761.6K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $46.73M $38.25M
Short-Term Investments $258.4M $70.54M
Cash & Short-Term Investments $453.1M $108.8M
Total Current Assets $324.7M $114.6M
Property, Plant & Equipment, Net $1.09M $1.21M
Long-Term Investments $148.0M $11.38M
Other Non-Current Assets $59K $3.17M
Total Non-Current Assets $154.8M $22.31M
Total Assets $479.5M $136.9M
Accounts Payable $3.29M $1.91M
Deferred Revenue (Current) $0 $3.24M
Total Current Liabilities $16.23M $15.92M
Total Non-Current Liabilities $4.91M $5.80M
Total Liabilities $21.14M $21.72M
Total Debt (incl. Leases) $5.80M $6.58M
Common Stock $5.0K $0
Retained Earnings -$360.5M -$199.4M
Accumulated Other Comp. Income -$228K $163K
Total Stockholders' Equity $458.4M -$193.6M
Total Equity $458.4M -$193.6M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2024-12-31
Cash & Cash Equivalents $55.57M $71.63M $55.71M $46.73M $64.15M $38.25M
Short-Term Investments $228.5M $233.1M $254.4M $258.4M $163.0M $70.54M
Cash & Short-Term Investments $284.1M $304.7M $310.1M $453.1M $227.2M $108.8M
Total Current Assets $294.6M $318.8M $327.2M $324.7M $245.3M $114.6M
Property, Plant & Equipment, Net $722K $828K $968K $1.09M $859K $1.21M
Long-Term Investments $179.3M $46.62M $85.09M $148.0M -- $11.38M
Other Non-Current Assets $14K $241K $36K $59K $5.14M $3.17M
Total Non-Current Assets $182.6M $49.56M $91.56M $154.8M $11.92M $22.31M
Total Assets $477.2M $368.3M $418.8M $479.5M $257.2M $136.9M
Accounts Payable $2.96M $2.05M $3.19M $3.29M $2.45M $1.91M
Deferred Revenue (Current) -- -- $0 $0 $1.21M $3.24M
Total Current Liabilities $30.90M $19.29M $14.28M $16.23M $18.56M $15.92M
Total Non-Current Liabilities $510K $755K $4.67M $4.91M $5.14M $5.80M
Total Liabilities $31.41M $20.05M $18.95M $21.14M $23.71M $21.72M
Total Debt (incl. Leases) $1.69M $1.99M $5.59M $5.80M $6.01M $6.58M
Common Stock $6.0K $5.0K $5.0K $5.0K $0 $0
Retained Earnings -$533.0M -$481.4M -$421.2M -$360.5M -$281.0M -$199.4M
Accumulated Other Comp. Income -$3.01M -$944K -$883K -$228K $46K $163K
Total Stockholders' Equity $445.8M $348.3M $399.8M $458.4M -$274.2M -$193.6M
Total Equity $445.8M $348.3M $399.8M $458.4M -$274.2M -$193.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$161.2M -$77.58M
Depreciation & Amortization $578K $701K
Stock-Based Compensation $36.01M $1.08M
Change in Payables $1.38M -$1.34M
Operating Cash Flow -$138.1M -$78.81M
Capital Expenditure -$473K -$770K
Free Cash Flow -$138.6M -$79.58M
Purchases of Investments -$408.2M -$125.0M
Investing Cash Flow -$323.2M -$80.79M
Financing Cash Flow $469.8M $118.1M
Net Change in Cash $8.48M -$41.54M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$51.62M -$60.19M -$60.67M -$79.55M -$29.42M -$29.84M -$22.34M -$21.23M
Depreciation & Amortization $135K $147K $162K $140K $100K $136K $166K --
Stock-Based Compensation $10.26M $8.63M $9.64M $35.52M $125K $148K $212K --
Change in Payables $894K -$1.13M -$111K $893K $301K $1.24M -$1.05M --
Operating Cash Flow -$35.68M -$44.87M -$51.18M -$46.83M -$31.79M -$33.97M -$25.55M --
Capital Expenditure -$12K -$22K -$24K -- -- -- -- --
Free Cash Flow -$35.69M -$44.89M -$51.20M -- -- -- -- --
Sales & Maturities of Investments $59.75M $80.50M $67.03M -- $6.50M $17.50M $37.50M --
Investing Cash Flow -$130.1M $60.70M $67.01M -$242.6M -$135.6M $17.43M $37.50M --
Financing Cash Flow $150.5M $92K -$6.85M $272.0M $198.1M -$156K -$47K --
Net Change in Cash -$15.20M $15.93M $8.98M -$17.42M $30.68M -$16.69M $11.90M --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Equity (ROE) -35.2% --
Return on Assets (ROA) -33.6% -56.7%
Current Ratio 20.01x 7.20x
Quick Ratio 27.92x 6.83x
Debt to Equity 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -56.5% -66.0% -49.9% -35.2% -- -- -- --
Return on Assets (ROA) -52.8% -62.4% -47.6% -33.6% -40.0% -- -- -56.7%
Current Ratio 9.53x 16.52x 22.91x 20.01x 13.22x -- -- 7.20x
Quick Ratio 9.19x 15.79x 21.71x 27.92x 12.24x -- -- 6.83x
Debt to Equity 0.00x 0.01x 0.01x 0.01x -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001770069) · from March 31, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:40 UTC · Open in terminal